ProfileGDS5678 / 1425864_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 18% 18% 18% 18% 18% 18% 16% 18% 18% 18% 18% 18% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4588618
GSM967853U87-EV human glioblastoma xenograft - Control 22.4395118
GSM967854U87-EV human glioblastoma xenograft - Control 32.4382718
GSM967855U87-EV human glioblastoma xenograft - Control 42.3888718
GSM967856U87-EV human glioblastoma xenograft - Control 52.3955318
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5004618
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4308816
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4158218
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4146318
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4297118
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4189718
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4140918
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4300918
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4272418